PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-51.02%
Negative revenue growth while NXPI stands at 3.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-46.54%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
-9.60%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-55.20%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
80.95%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
81.13%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
81.13%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.19%
Slight or no buybacks while NXPI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.19%
Slight or no buyback while NXPI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-3.21%
Dividend reduction while NXPI stands at 0.12%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
316.99%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
184.15%
FCF growth above 1.5x NXPI's 94.26%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-28.67%
Negative 10Y revenue/share CAGR while NXPI stands at 79.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-39.49%
Negative 5Y CAGR while NXPI stands at 77.31%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-62.42%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
64.38%
5Y OCF/share CAGR at 50-75% of NXPI's 107.18%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
39.55%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
-185.06%
Negative 10Y net income/share CAGR while NXPI is at 36.73%. Joel Greenblatt sees a major red flag in long-term profit erosion.
70.38%
Below 50% of NXPI's 328.95%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-115.93%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
91.70%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
88.43%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
33.93%
3Y equity/share CAGR at 75-90% of NXPI's 42.98%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
1.01%
Dividend/share CAGR of 1.01% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
19.89%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
42.45%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-17.25%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-29.91%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.06%
Negative asset growth while NXPI invests at 0.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.62%
We have a declining book value while NXPI shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
6.74%
We have some new debt while NXPI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-55.80%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-10.69%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.